PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for children and adults living with rare and serious disease.
Investor insights
Funding rounds participated in
$1B sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
1998
Funding rounds raised
Total raised
$1B
from investors over 1 rounds
P
PTC Therapeutics, Inc. raised $1B on November 27, 2022